💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…
Profile for Galectin Therapeutics Inc. (GALT)
« Back to company indexGALT Chatter Timeline
Stock Ticker for GALT
Most Active Tweeters for GALT
| User | Tweets |
|---|---|
| @RorutoTrade | 7 |
| @ShortAlgoTrades | 3 |
| @GalectinGALT | 2 |
| @Tickeron | 2 |
| @ElsayadAbdallah | 1 |
Recent Tweets for GALT
 |
@investor_feed $GALT 8-K Galectin Therapeutics (3 Dec, 12:00pm) ? Regulation FD Disclosure; Financial Statements and Exhibits… https://t.co/GW60xGHwAB December 3rd 2021, 5:12pm |
 |
@quantisnow $GALT ? Galectin Therapeutics Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits… https://t.co/GpY4zOqHJp December 3rd 2021, 5:12pm |
 |
@FlashAlert_me $GALT [15s. delayed] filed form 8-K on December 03, 12:00:19 https://t.co/6WI1FAK5bt December 3rd 2021, 5:12pm |
 |
@RorutoTrade $GALT Waiting for Buy signal on GALT with https://t.co/sxj8WuVZJB https://t.co/VzgEpOLGRQ December 3rd 2021, 3:12am |
 |
@ChartMill $GALT was analyzed by 7 analysts. The buy consensus is at 83%. So analysts seem to be very confident about $GALT.… https://t.co/RyZB25Ip3N December 3rd 2021, 1:12am |
 |
@ElsayadAbdallah $GALT Awaiting Buy Signal. Stock Trading Ideas by https://t.co/WBzNMhZu5y https://t.co/aPPW2FLaUC December 2nd 2021, 1:12pm |
 |
@OptionHunt Ticker $GALT Unusual Volume Detected: 57.28% over average December 1st 2021, 5:12pm |
|
@RorutoTrade $GALT Waiting for Buy signal on GALT with https://t.co/sxj8WuVZJB https://t.co/l5SQ2Wi1Gz December 1st 2021, 1:12am |
 |
@Tickeron $GALT's in Downtrend: Moving Average Convergence Divergence (MACD) Histogram just turned negative. View odds for th… https://t.co/s7UHolQxMR November 30th 2021, 9:11pm |
 |
@ShortAlgoTrades $GALT Awaiting buy Signal. Stock Trading Ideas by https://t.co/jpmUt7BvVp #Investing #trading https://t.co/jjTB9l4Aur November 30th 2021, 12:11pm |
|
@RorutoTrade $GALT Waiting for Buy signal on GALT with https://t.co/sxj8WuVZJB https://t.co/sCjNn458kP November 29th 2021, 8:11pm |
 |
@ShogunTrade $GALT Awaiting buy signal. Stock trading ideas by https://t.co/6vnULU2sSf https://t.co/QWymzAUkNS November 26th 2021, 2:11pm |
|
@RorutoTrade $GALT Waiting for Buy signal on GALT with https://t.co/sxj8WuVZJB https://t.co/sSesEUVzC6 November 26th 2021, 12:11am |
|
@RorutoTrade $GALT Waiting for Buy signal on GALT with https://t.co/sxj8WuVZJB https://t.co/bPPqMQeCKk November 25th 2021, 1:11am |
 |
@TradingChromat1 Awaiting Buy signal on $GALT https://t.co/VEyONTKGL5 November 24th 2021, 4:11pm |
 |
@GalectinGALT $GALT's research focuses on galectin-3. Galectin-3 is an important target because it triggers many pathological pro… https://t.co/rCp3SP4g6h November 24th 2021, 2:11pm |
 |
@JohnGaltCoin @TradeWithMarco Oh you mean the $GALT coin ;) ? November 23rd 2021, 5:11pm |
|
@Tickeron $GALT enters a Downtrend as Momentum Indicator dropped below the 0 level on November 5, 2021. View odds for this an… https://t.co/sWqpSd2eIP November 23rd 2021, 2:11pm |
|
@ShortAlgoTrades $GALT Awaiting Buy Signal. Stock Trading Ideas by https://t.co/jpmUt7BvVp https://t.co/BLbNsgmAt4 November 23rd 2021, 1:11pm |
|
@RorutoTrade $GALT Waiting for Buy signal on GALT with https://t.co/sxj8WuVZJB https://t.co/64pWtD5xDt November 22nd 2021, 11:11pm |
|
@GalectinGALT Are you interested in learning more about $GALT's adaptive Phase 2b/3 clinical trial focused on treating the sympto… https://t.co/koBKZq7bXA November 22nd 2021, 8:11pm |
|
@ShortAlgoTrades $GALT Awaiting buy signal. Stock Trading Ideas by https://t.co/jpmUt7BvVp https://t.co/aWGkNpGjpo November 22nd 2021, 2:11pm |
|
@RorutoTrade $GALT Waiting for Buy signal on GALT with https://t.co/sxj8WuVZJB https://t.co/LedUifGrsf November 20th 2021, 5:11am |
|
@RorutoTrade $GALT Waiting for Buy signal on GALT with https://t.co/sxj8WuVZJB https://t.co/7GuVhts6GJ November 19th 2021, 2:11am |
 |
@LeeSinTrade1 $GALT Awaiting Buy Signal. Algo Trading by https://t.co/z9Zossz5Nf https://t.co/0mV0T93JM8 November 18th 2021, 1:11pm |
|
@RorutoTrade $GALT Waiting for Buy signal on GALT with https://t.co/sxj8WuVZJB https://t.co/3TOFrixuZj November 18th 2021, 12:11am |
|
@Tickeron $GALT enters a Downtrend because Momentum Indicator dropped below the 0 level on November 5, 2021. View odds for th… https://t.co/XfBNN7CYM9 November 17th 2021, 9:11am |
|
@RorutoTrade $GALT Waiting for Buy signal on GALT with https://t.co/sxj8WuVZJB https://t.co/T3jUc42EWM November 16th 2021, 10:11pm |
|
@Tickeron $GALT in -9.15% Downtrend, falling for three consecutive days on November 11, 2021. View odds for this and other in… https://t.co/iOPunPkJPq November 16th 2021, 2:11pm |
|
@Tickeron Is this good for your portfolio? $GALT RSI Indicator left the oversold zone. #GalectinTherapeutics #stockmarket… https://t.co/m0YDslwCdr November 16th 2021, 12:11pm |
|
@GalectinGALT Today, $GALT reported its financial results for the quarter ended September 30, 2021 and provided a business update… https://t.co/NcVzaYRqHu November 15th 2021, 8:11pm |
 |
@SmallCapsDaily $GALT Galectin Therapeutics Reports Financial Results for the Quarter Ended September 30, 2021, and Provides Busine… https://t.co/ntbINgv44O November 15th 2021, 3:11pm |
|
@Tickeron Galectin Therapeutics to report earnings on November 16, 2021. Earnings per share (EPS) estimate: $-0.13 $GALT… https://t.co/ny98i8oYqh November 15th 2021, 3:11pm |
 |
@mediasentiment $GALT new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 249 November 15th 2021, 1:11pm |
 |
@MarcJacksonLA $GALT Galectin Therapeutics Reports Financial Results for the Quarter Ended September 30, 2021, and Provides Busine… https://t.co/bJAPg11O2l November 15th 2021, 1:11pm |
 |
@MarketCurrents $GALT - Galectin Therapeutics EPS beats by $0.04 https://t.co/2wdUtYmnwR November 15th 2021, 1:11pm |
 |
@63_hyacinth Galectin Therapeutics expects cash to fund operations through Mar. 31, 2023 $GALT November 15th 2021, 1:11pm |
|
@63_hyacinth Galectin Therapeutics expects to require more cash after Mar. 31, 2023 $GALT November 15th 2021, 1:11pm |
 |
@StockNewsBot2 $GALT Galectin Therapeutics Reports Financial Results for the Quarter Ended September 30, 2021, and Provides Busine… https://t.co/UgX7uKIWwz November 15th 2021, 1:11pm |
 |
@stock_titan $GALT Galectin Therapeutics Reports Financial Results for the Quarter Ended September 30, 2021, and Provides Busine… https://t.co/IfVSocf4XW November 15th 2021, 1:11pm |
 |
@fintel_io Also, if you are new to $GALT here's a background article on Finpedia for you https://t.co/ru4JW6JK8m #FNTL November 15th 2021, 12:11pm |
|
@investor_feed $GALT 8-K Galectin Therapeutics (15 Nov, 7:55am) ? Board approves exploration of a Company-sponsored belapecti… https://t.co/FtLiEOIUlf November 15th 2021, 12:11pm |
|
@fintel_io $GALT / Galectin Therapeutics files form 10-Q https://t.co/mQIu2BN5v8 #FNTL November 15th 2021, 12:11pm |
|
@investor_feed $GALT 10-Q Galectin Therapeutics (15 Nov, 7:51am) ? 2021 Q3 Earnings https://t.co/uHtoJqvLq6 #GALT #10Q… https://t.co/oJV97lbkv3 November 15th 2021, 12:11pm |
|
@ShogunTrade $GALT Awaiting Buy Signal. Stock Trading Ideas by https://t.co/6vnULU2sSf https://t.co/ISf3yWCDXZ November 15th 2021, 12:11pm |
|
@Tickeron Do you agree with the A.I. prediction? $GALT RSI Indicator left the oversold zone. #GalectinTherapeutics… https://t.co/v3arBbAgtk November 13th 2021, 10:11am |
|
@RorutoTrade $GALT Waiting for Buy signal on GALT with https://t.co/sxj8WuVZJB https://t.co/ngd5fyFrvi November 12th 2021, 6:11pm |
|
@Tickeron $GALT's 10-day Moving Average crossed below its 50-day Moving Average on October 12, 2021. View odds for this and o… https://t.co/DocXICtiPV November 12th 2021, 7:11am |
|
@Tickeron $GALT's 10-day Moving Average moved below its 50-day Moving Average on October 12, 2021. View odds for this and oth… https://t.co/EOrtHvRFwE November 11th 2021, 10:11pm |
|
@Tickeron If you’re trading this week, Read This! $GALT MACD Histogram turned negative on November 10, 2021.… https://t.co/TmADvGH5jP November 11th 2021, 9:11pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2021. All rights reserved.
DrugPatentWatch Video Training
Decision-making for generic drug entry and branded drug lifecycle management
By tracking patent expirations, patent litigation, generic and biosimilar development, you can anticipate these market-shaping forces and stay one step ahead.
This course answers the following questions to help you adapt:
- ✓ When will key drug patents expire?
- ✓ How can I find, evaluate, and plan for generic market entry opportunities?
- ✓ How can I find proprietary out-of-court settlements and deal terms?